NeoTract, Inc. Receives U.S. FDA De Novo Approval for the UroLift® Prostate Implant
September 16, 2013 8:00 amPLEASANTON, CA, – NeoTract, Inc., today announced that it received De Novo approval from the U.S. Food and Drug Administration (FDA) to market the novel UroLift® System,... Read More

